drugset
drugset / Trial / NCT03070405

The Effect of PAS on the Pharmacokinetics of Tenofovir in Healthy Subjects

NCT03070405 ↗

Phase 1 Unknown 20 enrolled Inje University
RandomizedCrossoverOpen-labelScreening

Summary

The main purpose of this study is to evaluate whether PAS will change the PK parameters of tenofovir.

Timeline

Start
2016-10
Primary completion
2017-03
Completion
2017-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Tenofovir disoproxil fumarate Small molecule 300 mg Oral
Subject para-aminosalicylic acid Unknown 5.28 g Oral

Indications

No indication recorded.